Showing results (61-70 of 250) with videos related to
Sort By:
Pageof 25
Drugs & Aging|October 24, 2000
Progress in colorectal cancer chemotherapy: how far have we come, how far to go?M E Royce, P M Hoff, R PazdurThe Oncologist|December 8, 2000
Pediatric oncology: regulatory initiativesS Hirschfeld, A Shapiro, R Dagher, et al.Current Oncology Reports|December 21, 2000
Novel oral chemotherapy agentsM E Royce, P M Hoff, R PazdurInvestigational New Drugs|January 1, 1994
Phase II trial of intravenous melphalan in advanced colorectal carcinomaD F Moore, R Pazdur, J L AbbruzzeseClinical Pharmacology and Therapeutics|January 12, 2017
Drug Development, Trial Design, and Endpoints in Oncology: Adapting to Rapidly Changing ScienceG M Blumenthal, K B Goldberg, R PazdurInvestigational New Drugs|December 16, 1998
Phase II study of prolonged infusion of Taxol in patients with metastatic colorectal carcinomaJ A Ajani, R Pazdur, P Dumas, et al.Cancer Investigation|April 29, 1998
Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day scheduleR Pazdur, Y Lassere, E Diaz-Canton, et al.Cancer|July 1, 1987
Prospective evaluation of adrenal insufficiency in patients with adrenal metastasisB G Redman, R Pazdur, A P Zingas, et al.Seminars in Oncology|October 1, 1994
A phase II trial of paclitaxel (Taxol) in advanced esophageal cancer: preliminary reportD Kelsen, J Ajani, D Ilson, et al.Pageof 25